FDA Drug Recalls

832 recalls, newest first

Jan 15, 2020 Class II · Moderate risk

Cholecalciferol

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0251-3 D-0993-2020

Jan 15, 2020 Class II · Moderate risk

Cholecalciferol

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0210-3 D-0992-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Diacetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0634-1 D-0991-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Diacetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0628-2 D-0990-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Diacetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0625-1 D-0989-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Acetonide

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0633-1 D-0988-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Acetonide

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0635-2 D-0987-2020

Jan 15, 2020 Class II · Moderate risk

Triamcinolone Acetonide/Bupivacaine Hydrochloride Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0632-1 D-0986-2020

Jan 15, 2020 Class II · Moderate risk

Testosterone Cypionate/Progesterone Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0531-2 D-0985-2020

Jan 15, 2020 Class II · Moderate risk

Testosterone Cypionate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0530-2 D-0984-2020

Jan 15, 2020 Class II · Moderate risk

Testosterone Cypionate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0530-1 D-0983-2020

Jan 15, 2020 Class II · Moderate risk

Super MIC Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0234-3 D-0982-2020

Jan 15, 2020 Class II · Moderate risk

Selenium Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0227-3 D-0981-2020

Jan 15, 2020 Class II · Moderate risk

Pyridoxine Hydrochloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0216-3 D-0980-2020

Jan 15, 2020 Class II · Moderate risk

Iohexol

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-1413-5 D-0979-2020

Jan 15, 2020 Class II · Moderate risk

Nicotinamide Adenine Dinucleotide

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0336-1 D-0978-2020

Jan 15, 2020 Class II · Moderate risk

Nicotinamide Adenine Dinucleotide

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0306-1 D-0977-2020

Jan 15, 2020 Class II · Moderate risk

Mitomycin-C

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0812-8 D-0976-2020

Jan 15, 2020 Class II · Moderate risk

MIC-PLUS Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0231-3 D-0975-2020

Jan 15, 2020 Class II · Moderate risk

MIC-PLEX Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0233-3 D-0974-2020

Jan 15, 2020 Class II · Moderate risk

MIC-B12 Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0230-3 D-0973-2020

Jan 15, 2020 Class II · Moderate risk

Methylprednisolone Acetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0636-1 D-0972-2020

Jan 15, 2020 Class II · Moderate risk

Methylprednisolone Acetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0619-1 D-0971-2020

Jan 15, 2020 Class II · Moderate risk

Methylprednisolone Acetate Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0639-2 D-0970-2020

Jan 15, 2020 Class II · Moderate risk

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0624-1 D-0969-2020

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061